These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17213597)

  • 21. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry.
    Lee CH; Wong HB; Tan HC; Zhang JJ; Teo SG; Ong HY; Low A; Sutandar A; Lim YT
    J Interv Cardiol; 2005 Aug; 18(4):261-6. PubMed ID: 16115155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction.
    Li J; Wu L; Tian X; Zhang J; Shi Y
    PLoS One; 2015; 10(6):e0119223. PubMed ID: 26035818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].
    Han YL; Deng J; Jing QM; Wang SL; Ma YY; Luan B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):483-6. PubMed ID: 16842659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
    Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute effects of intracoronary nitroglycerin and diltiazem in coronary slow flow phenomenon.
    Ozdogru I; Zencir C; Dogan A; Orscelik O; Inanc MT; Celik A; Gur M; Elbasan Z; Kalay N; Oguzhan A
    J Investig Med; 2013 Jan; 61(1):45-9. PubMed ID: 23222003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study.
    Aksu T; Guler TE; Colak A; Baysal E; Durukan M; Sen T; Guray U
    BMC Cardiovasc Disord; 2015 Feb; 15():10. PubMed ID: 25885120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of intracoronary thrombolysis versus percutaneous transluminal coronary angioplasty for treating acute myocardial infarction].
    Nakamura M; Yamaguchi T; Isshiki T; Nagahara T; Itaoka Y; Saeki F
    J Cardiol; 1992; 22(4):607-16. PubMed ID: 1343626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracoronary thrombectomy with the export aspiration catheter before angioplasty in patients with ST-segment elevation myocardial infarction.
    Cohen R; Domniez T; Foucher R; Sfaxi A; Elhadad S
    J Interv Cardiol; 2007 Apr; 20(2):136-42. PubMed ID: 17391222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined revascularization strategy for acute myocardial infarction in patients with intracoronary thrombus: preceding intracoronary thrombolysis and subsequent mechanical angioplasty.
    Ishibashi F; Saito T; Hokimoto S; Noda K; Moriyama Y; Oshima S
    Jpn Circ J; 2001 Apr; 65(4):251-6. PubMed ID: 11316117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine.
    Ishihara M; Sato H; Tateishi H; Kawagoe T; Shimatani Y; Kurisu S; Sakai K
    Am Heart J; 1996 Nov; 132(5):959-63. PubMed ID: 8892767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in TIMI frame count following successful reperfusion with stenting or percutaneous transluminal coronary angioplasty for acute myocardial infarction.
    Edep ME; Guarneri EM; Teirstein PS; Phillips PS; Brown DL
    Am J Cardiol; 1999 May; 83(9):1326-9. PubMed ID: 10235089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction.
    Pasceri V; Pristipino C; Pelliccia F; Granatelli A; Speciale G; Roncella A; Pironi B; Capasso M; Richichi G
    Am J Cardiol; 2005 Jun; 95(11):1358-61. PubMed ID: 15904643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction.
    Werner GS; Lang K; Kuehnert H; Figulla HR
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):444-51. PubMed ID: 12455077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction.
    Zhao JL; Fan CM; Yang YJ; You SJ; Gao X; Zhou Q; Pei WD
    Cardiovasc Ther; 2013 Feb; 31(1):60-4. PubMed ID: 21884027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
    Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
    Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Beneficial effects of diltiazem on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):679-83. PubMed ID: 15932731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.